Knight Therapeutics | GUD - Gewinn Vor Steuern

Aktienkurs
7.53
Täglich Wechseln
-0.12 -1.57%
Monatlich
21.45%
Jährlich
32.80%
Q2 Prognose
7.26




Gewinn Vor Steuern Veränderung Datum
Acasti Pharma USD -2.31M 1.38M 2025-12
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Avita Medical AUD -11.64M 12.13M 2025-12
Canopy Growth CAD -62.26M 60.84M 2025-12
Cronos Group USD 31.78M 70.78M 2025-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Ionis Pharmaceuticals USD -228M 99M 2025-12
IQVIA Holdings USD 6.16B 5.84B 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Moderna USD -187M 631M 2025-09
Omeros USD -65.12M 21.27M 2024-06
Organigram Holdings CAD -41.72M 25.52M 2025-09
Organon & Co USD 243M 14M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Tectonic Therapeutic USD -18.97M 63K 2025-12
Tilray USD -39.96M 39.19M 2025-09
Viatris USD -7.9M 209.2M 2025-09
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12